Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
28°
Light Snow
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
164.66
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
59
60
Next >
Where AbbVie Stands With Analysts
November 18, 2022
Via
Benzinga
Credit Suisse Says AbbVie's Humira Patent Cliff Could Provide Momentum to Boost Growth
November 18, 2022
Via
Benzinga
Analyst Ratings for AbbVie
November 18, 2022
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 18, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
What 8 Analyst Ratings Have To Say About AbbVie
November 18, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Upgrades
Via
Benzinga
What Does AbbVie's Debt Look Like?
November 18, 2022
Over the past three months, shares of AbbVie's Inc. (NYSE:ABBV) rose by 11.27%. Before having a look at the importance of debt, let's look at how much debt AbbVie's has.
Via
Benzinga
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID
November 17, 2022
Palm Beach, FL – November 17, 2022 – FinancialNewsMedia.com News Commentary – Since the beginning of the pandemic, the critical effort of researchers is to understand how coronavirus damages the body....
Via
FinancialNewsMedia
Exposures
COVID-19
AbbVie's Migraine Treatment Scores Canadian Approval
November 16, 2022
Via
Benzinga
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
November 16, 2022
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry.
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Exicure Flags Bankruptcy Concerns, Shares Fall
November 15, 2022
Via
Benzinga
2 Top Stocks to Buy in November and Hold Forever
November 13, 2022
Today is a great time to enter these long-term stories.
Via
The Motley Fool
This Healthcare Stock Disappointed Investors. Here's Why It's Still a Buy.
November 09, 2022
AbbVie's strong portfolio has what it takes to drive long-term growth.
Via
The Motley Fool
The Dividend Capture Strategy: What Investors Need To Know
November 12, 2022
This article will examine the dividend capture strategy, discuss the advantages and risks of the strategy, and provide a few examples of stocks that could be a good way for an investor to utilize this...
Via
Talk Markets
6 Dividend Growth Stocks
November 12, 2022
Want to know about dividend growth stocks that are increasing their dividends yet again? Today I want to tell you about six dividend growth stocks that just increased their dividends.
Via
Talk Markets
7 No-Brainer Dividend Stocks to Buy for 2023 and Beyond
November 10, 2022
With circumstances getting a tad too rough in the market, it’s time for investors to pivot toward no-brainer dividend stocks to buy.
Via
InvestorPlace
3 Top Healthcare Stocks Defying the Bear Market
November 10, 2022
These healthcare companies haven't been slowed by macroeconomic conditions.
Via
The Motley Fool
If You Like Dividends, You Should Love These 3 Stocks
November 09, 2022
These stocks are crushing the market this year and still have tremendous profit potential.
Via
The Motley Fool
3 Reasons to Buy AbbVie Stock Right Now
November 05, 2022
The drugmaker has something to offer to all kinds of investors.
Via
The Motley Fool
Why Dividend Investors Can Still Buy AbbVie Stock With No Worries
November 03, 2022
The big-pharma company's dividend remains safe and sound.
Via
The Motley Fool
The 7 Best Pharma Stocks to Buy Now
November 08, 2022
Investors searching for gains in the current market storm should consider taking a position in some of the best pharma stocks.
Via
InvestorPlace
Investing $1,000 in the Current Market? Don't Overlook These 2 Winning Dividend Stocks
November 08, 2022
Just because the stock market is going haywire doesn't mean you have to sit on the sidelines.
Via
The Motley Fool
These 3 Dividend ETFs Are a Retiree's Best Friend
November 08, 2022
This trio of exchange-traded funds has trounced the S&P 500 this year.
Via
The Motley Fool
Control Of Congress Up For Grabs In Midterms: 12 Stocks To Watch
November 07, 2022
As voters endeavor to select the congressional candidates they believe would best assist the U.S. in navigating through historical issues it is currently facing, investors are wondering what's going to...
Via
Benzinga
3 Dividend Kings Crushing The S&P 500 In 2022
November 05, 2022
Income investors love to target Dividend Aristocrats, companies that have increased their dividend payouts for a minimum of 25 consecutive years.
Via
Talk Markets
3 No-Brainer Dividend Stocks to Buy in November
November 05, 2022
There's no need for agonizing decision-making with these great dividend stocks.
Via
The Motley Fool
MarketBeat: Week in Review 10/31-11/4
November 05, 2022
You can count on MarketBeat to point you towards the stocks that are good opportunities. Here are some of the most popular articles from this week
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
2 Dividend Growth Stocks to Buy and Hold for Years
November 04, 2022
These companies have been raising their dividends by an average of more than 10% over the past five years.
Via
The Motley Fool
Better Buy: AbbVie vs. Walgreens Boots Alliance
November 04, 2022
Both these companies pay a dividend, but the similarities stop there.
Via
The Motley Fool
3 Top Healthcare Stocks to Buy for November
November 04, 2022
Catalysts lie ahead for these promising stocks.
Via
The Motley Fool
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
59
60
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.